CTA News

Home/CTA News
CTA News2020-03-15T11:08:35+00:00

CTA CEO discusses key considerations for Chinese biotechs considering conducting clinical trials in Australia

November 15th, 2019|

Cancer Trials Australia’s CEO, Dr. Kurt Lackovic, was a panelist at the 12th annual ‘China Trials – Clinical Development Leaders’ summit’ in Shanghai this week.  Other panelists included Jayden [...]

CTA announces partnership to drive Teletrials forward at Victorian study sites

November 11th, 2019|

Cancer Trials Australia (CTA) is pleased to announce a new project, to be delivered with the Victorian Comprehensive Cancer Centre (VCCC), providing Victorian sites with an exciting opportunity to [...]

CTA CEO presents at 3rd Annual Accelerating Clinical Trials in Asia conference

September 26th, 2019|

By 2021, the global market for clinical trials is anticipated to grow to $60Bn, a 75% increase over 2015. The largest contributor to this huge growth is the Asia-Pacific region.Cancer [...]

Coordinated Electronic Document Management for Victorian study sites

November 22nd, 2018|

CTA announces partnership in delivering coordinated Electronic Document Management for Victorian study sites Cancer Trials Australia (CTA) is pleased to announce a new project funded by the Victorian Comprehensive [...]

Fast, Quality Clinical Trials for Less: Let Melbourne, Australia be Your Partner

April 30th, 2018|

Cancer Trials Australia's CEO, Dr Kurt Lackovic, was recently invited to speak at an international webinar showcasing Melbourne as a premier location for the conduct of Phase 1 clinical trials. Aimed primarily at international [...]